Challenges in the therapy of chromoblastomycosis (Q38103473)

28 August 2017

Challenges in the therapy of chromoblastomycosis (English)

1 reference

28 August 2017

Flavio Queiroz-Telles

series ordinal

1

1 reference

PubMed ID

23636730

28 August 2017

Daniel Wagner de C L Santos

series ordinal

2

1 reference

28 August 2017

2 May 2013

1 reference

28 August 2017

12

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

28 August 2017

175

1 reference

28 August 2017

477-488

1 reference

28 August 2017

5-6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11046-013-9648-x

28 August 2017

0 references

cites work

Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Chromoblastomycosis: clinical and mycologic experience of 51 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Melanized fungi in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Management of chromoblastomycosis: novel perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Genetic diversity and species delimitation in the opportunistic genus Fonsecaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Treating chromoblastomycosis with systemic antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Cell mediated immunity to fungi: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

The immune response to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Topical Heat Therapy for Cutaneous Chromomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Successful treatment of chromoblastomycosis with topical heat therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Killing of cutaneous microbial species by photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Photodynamic antifungal therapy against chromoblastomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Photodynamic therapy for pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Ajoene and 5-fluorouracil in the topical treatment of Cladophialophora carrionii chromoblastomycosis in humans: a comparative open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Treatment of chromoblastomycosis with terbinafine: experience with four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Treatment of chromoblastomycosis with terbinafine: a report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Phaeohyphomycosis in a tertiary care cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

Immunity to fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-013-9648-X

21 January 2018

1 reference

12 December 2020

Treatment of chromomycosis with ketoconazole and 5-fluorocytosine

1 reference

12 December 2020

Treatment of chromoblastomycosis

1 reference

12 December 2020

Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil

1 reference

12 December 2020

Chromomycosis--report of two cases successfully treated with local heat therapy

1 reference

12 December 2020

On the priority of description of chromomycosis.

1 reference

12 December 2020

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis

1 reference

12 December 2020

Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics

1 reference

12 December 2020

Photodynamic antimicrobial chemotherapy (PACT)

1 reference

12 December 2020

A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis

1 reference

12 December 2020

Itraconazole for deep mycoses: preliminary experience in Mexico

1 reference

12 December 2020

A chronic chromoblastomycosis model byFonsecaea monophorain Wistar rat

1 reference

12 December 2020

Treatment of chromomycosis with itraconazole

1 reference

12 December 2020

A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei

1 reference

12 December 2020

Acrotheca aquaspersa nova, new species agent of chromomycosis

1 reference

12 December 2020

In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi

1 reference

12 December 2020

Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy

1 reference

12 December 2020

The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis.

1 reference

12 December 2020

Treatment of chromoblastomycosis with itraconazole

1 reference

12 December 2020

Chromoblastomycosis caused by Exophiala spinifera

1 reference

12 December 2020

Clinical and mycological spectra of Wangiella dermatitidis infections

1 reference

12 December 2020

1 reference

12 December 2020

Infections caused by dematiaceous fungi: chromoblastomycosis and phaeohyphomycosis

1 reference

12 December 2020

Persistent viability of the Medlar body

1 reference

12 December 2020

1 reference

12 December 2020

Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform

1 reference

12 December 2020

[Treatment of chromoblastomycosis with amphotericin B and 5-fluorocytosine]

1 reference

12 December 2020

The role of glucan in the prevention and modification of microparasitic diseases.

1 reference

12 December 2020

In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs

1 reference

12 December 2020

The implications and management of drug interactions with itraconazole, fluconazole and terbinafine

1 reference

12 December 2020

10.1007/S11046-013-9648-X

Identifiers

DOI

1 reference

PubMed ID

23636730

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23636730